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A B S T R A C T
We describe a patient with symptoms of heart failure caused by severe mitral regurgitation.
Echocardiography revealed an intracardiac mass embedding the posterior mitral valve leaﬂet, and
cardiac magnetic resonance imaging showed two intracardiac thrombi and endomyocardial ﬁbrosis.
Eosinophil count kept rising and amutation in the gene for platelet-derived growth factor receptor alpha
was found. The combination of these ﬁndings led to the diagnosis of Loefﬂer’s endocarditis. Treatment
with prednisone and a tyrosine kinase inhibitor resulted in complete remission of the hypereosinophilia
and mitral valve regurgitation was only mild at 9-month follow-up visit.
<Learning objective: This case report presents a patient with severe mitral regurgitation and heart
failure due to hypereosinophilic syndrome (HES). It leads to thrombus formation and endomyocardial
thickening due to eosinophilic inﬁltration of the myocardium. Treatment with steroids and a tyrosine
kinase inhibitor led to clinical improvement and only mild mitral regurgitaton after 6 months. Loefﬂer’s
endomyocarditis is a model disease for restrictive cardiomyopathy. It is important to recognize and treat
this disease early and preventmorbidity andmortality. As far aswe know there is no previous case report
that describes the reversibility of severemitral regurgitation after pharmacological treatment of HES, not
needing mitral valve replacement.>
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.Introduction
We describe a patient presenting with heart failure due to
severe mitral regurgitation and hypereosinophilia, conﬁrmed to be
Loefﬂer’s endomyocarditis. It was successfully treated with
steroids and imatinib and the patient was at New York Heart
Association (NYHA) class I after 9-month follow up and mitral
regurgitation was only mild at that time. Although several case
reports describe cases of Loefﬂer’s endocarditis, this case report
shows a case of a relatively young patient with potential fully
reversible disease if recognized and treated early.
Case report
A 51-year-old woman with unremarkable medical history was
admitted with chest pain, dyspnea at rest, orthopnea, and leg* Corresponding author at: Maastricht University Medical Centre,
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1878-5409/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightedema. Blood pressure was 120/80 mmHg, heart rate 115 bpm and
regular. Clinical examination revealed signs of heart failure and a
mitral regurgitation murmur on auscultation. Left atrial dilatation
and nonspeciﬁc repolarization abnormalities were seen on
electrocardiography (ECG) and pulmonary congestion on chest
X-ray. Initial laboratory results showed slight elevation of
troponin-I to 0.64 mg/L (norm: <0.04mg/L) and iron deﬁciency
[ferritin 11mg/L (20–250mg/L)] with microcytemic anemia
[hemoglobin 5.2 mmol/L (7.5–10.0 mmol/L), mean corpuscular
volume 81 fL (82–98 fL)]. The eosinophilic granulocyte count was
high: 13.1% (1.0–6.0%), absolute count 1.80  109/L.
Intravenous diuretics led to clinical improvement. On coronary
angiography, only mild wall irregularities were detected. Echo-
cardiography showed a hyperdynamic left ventricle, and eccentric
grade 4 mitral valve regurgitation. Estimated right ventricular
systolic pressurewas elevated. Transesophageal echocardiography
showed retraction of the posteriormitral leaﬂet by abnormal tissue
located posterior to this leaﬂet (Fig. 1). Cardiacmagnetic resonance
imaging (CMR) revealed the presence of two thrombi, one in the
apex and one basal-laterally located (Fig. 2 and Video 1), which
partially embedded the posterior mitral valve leaﬂet, evoking the
severe mitral regurgitation. Late gadolinium enhancement dem-
onstrated an increased signal intensity subendocardially arounds reserved.
[(Fig._1)TD$FIG]
Fig. 1.
Transesophageal echocardiography: severe mitral valve insufﬁciency detected with color Doppler imaging (left), due to a mass embedding the posterior mitral
valve leaﬂet (right).
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and Loefﬂer’s endocarditis. This increased signal intensity was also
seen diffusely at the border of myocardial tissue and the lumen.
Supplementary Video 1 related to this article can be found, in the
online version, at http://dx.doi.org/10.1016/j.jccase.2014. 05.012.
Eosinophilic granulocyte count reached its maximum of 46.0%
(absolute count 6.12  109/L), without any secondary cause for this
eosinophilia. Bone marrow aspiration disclosed mostly eosino-
philic granulocytes, leading to the diagnosis of myeloproliferative
hypereosinophilic syndrome (HES) due to chronic eosinophilic
leukemia (CEL). Therefore, prednisone was started intravenously.
Cytogenetic testing was performed presenting a mutation in the
gene for the platelet-derived growth factor receptor alpha
(PDGFRa). This mutation displays constitutive tyrosine kinase
activity; hence we added a tyrosine-kinase inhibitor (imatinib) to
the treatment regimen of our patient. Also, oral anticoagulant
therapy was initiated.
Eosinophil count normalized during follow-up and echocardi-
ography after 9 months showed only mild residual mitral valve
regurgitation and the patient was in NYHA class I. There was no
need for surgical treatment (mitral valve replacement).[(Fig._2)TD$FIG]
Fig. 2.
Cardiac magnetic resonance late enhancement image showing left
ventricular thrombi in the apex and basal–lateral.Discussion
In 1936,Wilhelm Loefﬂer described a type of endo(myo)carditis
caused by inﬁltration of eosinophils (Loefﬂer’s endocarditis),
which can cause serious cardiac complications, stressing the need
for early diagnosis and treatment. In the absence of secondary
causes of peripheral eosinophilia, Loefﬂer’s endocarditis is mainly
caused by HES. It progresses through three stages: a necrotic stage
with eosinophilic inﬁltration of the myocardium, a thrombotic
stage, and a ﬁnal ﬁbrotic stage resulting in restrictive cardiomy-
opathy [1].
Diagnostic criteria of HES include:1. Persistent eosinophilia of 1500 eosinophils/mm3 for >6
months;2. Lack of known causes of eosinophilia;
3. Signs and symptoms of organ involvement by eosinophilic
inﬁltration.
HES is a rare disease with an incidence in the USA of 0.035 per
100,000, with a male-to-female ratio of 1.47 and age of onset
between 20 and 50 years. Particularly when PDGFRa associated, it
has a high incidence of potentially lethal cardiac complications if
untreated [2]. Prevalence of cardiac involvement is 50–75%.
In Loefﬂer’s endocarditis, typical echocardiographic ﬁndings
include progressive endo(myo)cardial thickening, intracardiac
thrombus formation, and mitral regurgitation due to entrap-
ment of the chordae tendinae of the posterior leaﬂet during
the ﬁbrotic stage of this disease. Often, restrictive ﬁlling pattern
of the left ventricle is present [3]. Echocardiography may
underestimate the extent of mural thrombosis. CMR has a higher
sensitivity and speciﬁcity for detection of ventricular thrombi
and can obviate the need for frequent endomyocardial biopsy
[4]. False negative ﬁndings occur in right ventricle (RV) biopsies
and complications are common. For that reason and lack of
residual diagnostic uncertainty, we did not perform RV biopsy in
our patient.
Intracardiac thrombi are frequent due to expression of tissue
factor by inﬁltrating eosinophils [2]. Anticoagulant therapy is
advised, though not always effective. Corticosteroids are the
cornerstone of treatment of hypereosinophilia. For PDGFRa/b
related neoplasms with eosinophilia (e.g. CEL), a new effective
treatment modality (imatinib, a tyrosine-kinase inhibitor) has
emerged. This emphasizes the importance to seek for thismutation
in CEL patients.
Valve repair or replacement in persisting valvular regurgitation
and endocardectomy in advanced disease are surgical treatment
options. Postoperative mechanical valve thrombosis in persisting
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medical treatment before surgery is performed [5]. Our patient
responded well to medical treatment and at 9-month follow-up
residual mitral valve insufﬁciency was only mild. Valve repair or
replacement will therefore not be necessary in our patient.
In conclusion, Loefﬂer’s endocarditis is a rare and treatable
cause of heart failure and valvular heart disease due to
endo(myo)cardial thickening and thrombus formation and is
considered a model disease of restrictive cardiomyopathy.
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